| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/20/2002 | CA2431326A1 Pyrrolo (2.1-a) dihydroisoquinolines and their use as phosphodiesterase 10a inhibitors |
| 06/20/2002 | CA2431322A1 Medicinal compositions having improved absorbability |
| 06/20/2002 | CA2431319A1 Pharmaceutical composition having an improved water solubility |
| 06/20/2002 | CA2431107A1 Antitumoral carbazoles |
| 06/20/2002 | CA2430906A1 Proteins associated with cell growth, differentiation, and death |
| 06/20/2002 | CA2430905A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | CA2430736A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/20/2002 | CA2430454A1 Cddo-compounds and combination therapies thereof |
| 06/20/2002 | CA2430297A1 Interferon-alpha induced gene |
| 06/20/2002 | CA2430151A1 Phenylacetamido- pyrazole derivatives and their use as antitumor agents |
| 06/20/2002 | CA2429952A1 Method for generating immortal dendritic cell lines |
| 06/20/2002 | CA2429755A1 Treatment and prevention of ebv infection and ebv-associated disorders |
| 06/20/2002 | CA2429352A1 Antiviral agents for treatment of flaviviridae infections |
| 06/20/2002 | CA2428216A1 Secreted proteins |
| 06/19/2002 | EP1215214A1 Novel polypeptide |
| 06/19/2002 | EP1215212A2 Dihydro derivatives of LL-E33288 antibiotics |
| 06/19/2002 | EP1215203A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 06/19/2002 | EP1214946A2 Compositions and method for MRI-imaging malignant tumors using carbon 13 |
| 06/19/2002 | EP1214945A2 Method and medicament for inhibiting the expression of a defined gene |
| 06/19/2002 | EP1214942A2 Use of dendritic cells, loaded with bacteriophages which carry a tumour-specific and/or tumour-associated antigen on their surface, for treatment of tumours |
| 06/19/2002 | EP1214938A2 Modulation of cellular response to external stimuli |
| 06/19/2002 | EP1214933A1 Method for modulating the metabolism of nitrogen oxides, compositions therefor (and variants) and method for acting on a patient's organism necessitating the metabolism of nitrogen oxides to be corrected |
| 06/19/2002 | EP1214453A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 06/19/2002 | EP1214452A1 Method for identifying novel genes involved in the regulation of angiogenesis, study of said genes and use thereof for therapeutic purposes |
| 06/19/2002 | EP1214443A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214404A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 06/19/2002 | EP1214398A2 Chimeric virus-like particles or chimeric capsomers from bpv |
| 06/19/2002 | EP1214396A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 06/19/2002 | EP1214347A2 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 06/19/2002 | EP1214346A1 A novel angiogenesis inhibitor |
| 06/19/2002 | EP1214345A2 Agents for treating human diseases, especially for treating tumors such as colonic cancers and melanomas or for regenerating tissue and promoting hair growth |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214326A1 Inhibitors of prenyl-protein transferase |
| 06/19/2002 | EP1214325A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214324A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/19/2002 | EP1214318A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 06/19/2002 | EP1214305A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of inflammation |
| 06/19/2002 | EP1214304A1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes |
| 06/19/2002 | EP1214300A2 Rate-controlled particles |
| 06/19/2002 | EP1214298A2 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| 06/19/2002 | EP1214291A1 Biphenyl derivatives used as nhe-3 inhibitors |
| 06/19/2002 | EP1214101A1 Method for detecting and killing epithelial cancer cells |
| 06/19/2002 | EP1214098A1 Capsid-modified recombinant adenovirus and methods of use |
| 06/19/2002 | EP1214097A1 Nucleic acids encoding polyepitope polypeptides |
| 06/19/2002 | EP1214096A2 Taxane prodrugs |
| 06/19/2002 | EP1214092A2 Method of potentiating chemotherapy and treating solid tumors |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214078A1 Formulations for parenteral use of estramustine phosphate and amino acids |
| 06/19/2002 | EP1214070A2 Polyhydroxylated benzene-containing compounds |
| 06/19/2002 | EP1214067A1 Methods for treating cell proliferative disorders including cancer |
| 06/19/2002 | EP1214063A1 Method of treating cancer using tetraethyl thiuram disulfide |
| 06/19/2002 | EP1214061A2 Use of docetaxel for treating hepatocellular carcinoma |
| 06/19/2002 | EP1214053A1 Adjuvant comprising a polyoxyethylene alkyl ether or ester and at least one nonionic surfactant |
| 06/19/2002 | EP1214040A1 Extracts of orange peel for prevention and treatment of cancer |
| 06/19/2002 | EP1105395B1 Photocyclized rapamycins |
| 06/19/2002 | EP1042326B1 Novel acronycine derivatives, preparation method and pharmaceutical compositions |
| 06/19/2002 | EP1001769B1 Soluble prodrugs of paclitaxel |
| 06/19/2002 | EP0980354B1 Vitamin d3 analogs with bis c-20 side chains |
| 06/19/2002 | EP0885233B1 Terpyridine-platinum(ii) complexes |
| 06/19/2002 | EP0861084B1 Improved process and composition for therapeutic cisplatin (cddp) |
| 06/19/2002 | EP0730474B1 Estramustine formulations with improved pharmaceutical properties |
| 06/19/2002 | EP0625204B1 Hepatitis therapeutics |
| 06/19/2002 | CN1354882A Method of sterilizing radioactive seeds |
| 06/19/2002 | CN1354791A Compositions for treatment and diagnosis of breast cancer and methods for their use |
| 06/19/2002 | CN1354787A Process for purifying human papillomavirus virus-like particles |
| 06/19/2002 | CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/19/2002 | CN1354750A Amine derivatives compounds |
| 06/19/2002 | CN1354678A Polyethyleneimine: DNA formulations for aerosol delivery |
| 06/19/2002 | CN1354675A Adjuvant combination formulations |
| 06/19/2002 | CN1354672A Composition comprising alkaline sphingomyelinase for use as dietetic preparation, food supplement or pharmaceutical product |
| 06/19/2002 | CN1354668A Isolated peptides which bind to HLA-B35 molecules |
| 06/19/2002 | CN1354667A Use of camptotheicin derivatives with reduced gastrointestinal toxicity |
| 06/19/2002 | CN1354663A Sulfonamide and sulfamide substituted imidazoquinolines |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1354184A Method for synthesizing 2-methoxyestradiol and application of its product |
| 06/19/2002 | CN1354017A RIZ gene medicine composition and its application for curing cancer |
| 06/19/2002 | CN1354011A Preparation method of medicine for curing liver cancer |
| 06/19/2002 | CN1353985A Matter or composition for treatment of cancer |
| 06/19/2002 | CN1086389C Isoesperamicin and its synthesizing process |
| 06/19/2002 | CN1086386C Multi-drug resistance modifier |
| 06/18/2002 | US6407278 Stable amorphous amifostine compositions and methods for the preparation and use of the same |
| 06/18/2002 | US6407265 Tin polyoxaalkanecarboxylates and compositions containing them |
| 06/18/2002 | US6407244 Antiproliferative agent |
| 06/18/2002 | US6407239 Topoisomerase inhibitors |
| 06/18/2002 | US6407236 Tumor diagnosis; antiinflammatory agents; antiischemic agents; antidepressants |
| 06/18/2002 | US6407213 Method for making humanized antibodies |
| 06/18/2002 | US6407140 Autoimmune diseases, graft versus host disease and organ transplant surgery; pyrazole derivative mixture |
| 06/18/2002 | US6407131 5-carbonyloxy-1h-benzimidazole-2-carbamate derivatives |
| 06/18/2002 | US6407114 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/18/2002 | US6407103 Potent enzyme inhibitors of cyclin-dependent kinases relating to the catalytic subunits cdk1-9 and their regulatory subunits cyclins a-h; antiproliferative, -carcinogenic and -tumor agents; viricides; modulators of dna/rna biosynthesis |
| 06/18/2002 | US6407102 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological cell proliferation |
| 06/18/2002 | US6407101 Progesterone receptor antagonists; contraceptives, hormone replacement therapy; breast and prostate cancer treatment; menopause |
| 06/18/2002 | US6407075 Administering g-linolenic acid and doxorubicin to reduce side effects from anticarcinogenic chemotherapy |
| 06/18/2002 | US6407067 Salts of thrombin inhibitors |
| 06/18/2002 | US6407063 Tumor antigens and CTL clones isolated by a novel procedure |
| 06/18/2002 | US6407058 Phosphorylation of serine or threonine |
| 06/18/2002 | US6406861 Viral diseases and immunogens |
| 06/18/2002 | US6406681 Propellents and drugs |